News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Nuss John
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 9,277 shares
@ $29.937, valued at
$277.7k
Sold 723 shares
@ $30.7155, valued at
$22.2k
Exercised 1,401 options to buy
@ $0.2, valued at
$280.2
Exercised 7,972 options to buy
@ $3.54, valued at
$28.2k
Exercised 627 options to buy
@ $8.04, valued at
$5k
|
|
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/04/2023 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 8,887 shares
@ $35.5587, valued at
$316k
Sold 1,113 shares
@ $35.9171, valued at
$40k
Exercised 10,000 options to buy
@ $0.2, valued at
$2k
|
|
| 08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/05/2023 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 327 shares
@ $33.5442, valued at
$11k
Sold 142 shares
@ $34.7231, valued at
$4.9k
Sold 20 shares
@ $35.2737, valued at
$705.5
Sold 2,266 shares
@ $38.3193, valued at
$86.8k
Sold 1,563 shares
@ $39.3348, valued at
$61.5k
Sold 15,682 shares
@ $39.9643, valued at
$626.7k
Exercised 20,000 options to buy
@ $0.2, valued at
$4k
|
|
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/07/2023 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 8,322 shares
@ $34.287, valued at
$285.3k
Sold 1,678 shares
@ $34.6429, valued at
$58.1k
Exercised 10,000 options to buy
@ $0.2, valued at
$2k
|
|
| 06/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/05/2023 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 29,900 shares
@ $32.8721, valued at
$982.9k
Sold 100 shares
@ $33.57, valued at
$3.4k
Exercised 30,000 options to buy
@ $0.2, valued at
$6k
|
|
| 01/18/2023 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 108,750 options to buy
@ $33.84, valued at
$3.7M
Granted 18,125 restricted stock units
@ $0 |
|
| 12/20/2022 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Exercised 34,931 options to buy
@ $0 |
|
| 12/15/2022 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 35,000 shares
@ $34.3165, valued at
$1.2M
|
|
| 12/06/2022 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 46,706 shares
@ $28.1616, valued at
$1.3M
Sold 3,294 shares
@ $29.1426, valued at
$96k
|
|
| 02/04/2022 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 145,000 options to buy
@ $12.21, valued at
$1.8M
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|